You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

  • Technology appraisal guidance
  • Reference number: TA229
  • Published:  27 July 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders
17 November 2014
(36.3 Kb 10 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 17 November 2014

Back to top